BIIB logo

Biogen (BIIB) Gross profit

Annual gross profit:

$7.37B+$63.30M(+0.87%)
December 31, 2024

Summary

  • As of today (April 16, 2025), BIIB annual gross profit is $7.37 billion, with the most recent change of +$63.30 million (+0.87%) on December 31, 2024.
  • During the last 3 years, BIIB annual gross profit has fallen by -$1.51 billion (-16.98%).
  • BIIB annual gross profit is now -40.71% below its all-time high of $12.42 billion, reached on December 31, 2019.

Performance

BIIB Gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBincome statement metrics

quarterly gross profit:

$1.87B+$44.10M(+2.41%)
December 31, 2024

Summary

  • As of today (April 16, 2025), BIIB quarterly gross profit is $1.87 billion, with the most recent change of +$44.10 million (+2.41%) on December 31, 2024.
  • Over the past year, BIIB quarterly gross profit has increased by +$44.10 million (+2.41%).
  • BIIB quarterly gross profit is now -42.79% below its all-time high of $3.27 billion, reached on June 30, 2020.

Performance

BIIB quarterly gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBincome statement metrics

TTM gross profit:

$7.37B+$103.20M(+1.42%)
December 31, 2024

Summary

  • As of today (April 16, 2025), BIIB TTM gross profit is $7.37 billion, with the most recent change of +$103.20 million (+1.42%) on December 31, 2024.
  • Over the past year, BIIB TTM gross profit has increased by +$103.20 million (+1.42%).
  • BIIB TTM gross profit is now -42.21% below its all-time high of $12.74 billion, reached on June 30, 2020.

Performance

BIIB TTM gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBincome statement metrics

Gross profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

BIIB Gross profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+0.9%+2.4%+1.4%
3 y3 years-17.0%+2.4%+1.4%
5 y5 years-40.7%+2.4%+1.4%

BIIB Gross profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-17.0%+0.9%-11.1%+7.0%-12.7%+1.6%
5 y5-year-40.7%+0.9%-42.8%+7.0%-42.2%+1.6%
alltimeall time-40.7%+7569.7%-42.8%+495.9%-42.2%+7569.8%

Biogen Gross profit History

DateAnnualQuarterlyTTM
Dec 2024
$7.37B(+0.9%)
$1.87B(+2.4%)
$7.37B(+1.4%)
Sep 2024
-
$1.83B(-4.8%)
$7.26B(-0.6%)
Jun 2024
-
$1.92B(+9.8%)
$7.31B(+0.8%)
Mar 2024
-
$1.75B(-1.1%)
$7.25B(-0.7%)
Dec 2023
$7.30B(-7.5%)
$1.77B(-5.5%)
$7.30B(-2.7%)
Sep 2023
-
$1.87B(+0.4%)
$7.51B(-2.2%)
Jun 2023
-
$1.86B(+3.5%)
$7.68B(-3.1%)
Mar 2023
-
$1.80B(-8.8%)
$7.92B(+0.3%)
Dec 2022
$7.90B(-11.0%)
$1.97B(-3.2%)
$7.90B(-1.3%)
Sep 2022
-
$2.04B(-3.1%)
$8.00B(-2.8%)
Jun 2022
-
$2.11B(+18.4%)
$8.22B(-2.5%)
Mar 2022
-
$1.78B(-14.3%)
$8.43B(-4.9%)
Dec 2021
$8.87B(-23.8%)
$2.07B(-8.5%)
$8.87B(-3.1%)
Sep 2021
-
$2.27B(-2.1%)
$9.16B(-6.7%)
Jun 2021
-
$2.32B(+4.5%)
$9.82B(-8.9%)
Mar 2021
-
$2.22B(-6.2%)
$10.78B(-7.4%)
Dec 2020
$11.64B(-6.3%)
$2.36B(-19.3%)
$11.64B(-6.9%)
Sep 2020
-
$2.93B(-10.5%)
$12.50B(-1.9%)
Jun 2020
-
$3.27B(+6.2%)
$12.74B(+1.0%)
Mar 2020
-
$3.08B(-4.5%)
$12.61B(+1.5%)
Dec 2019
$12.42B(+6.8%)
$3.22B(+1.7%)
$12.42B(+1.5%)
Sep 2019
-
$3.17B(+0.9%)
$12.24B(+1.6%)
Jun 2019
-
$3.14B(+8.7%)
$12.04B(+1.7%)
Mar 2019
-
$2.89B(-4.9%)
$11.84B(+1.7%)
Dec 2018
$11.64B(+9.3%)
$3.04B(+2.0%)
$11.64B(+2.1%)
Sep 2018
-
$2.98B(+1.5%)
$11.40B(+2.4%)
Jun 2018
-
$2.94B(+9.3%)
$11.13B(+2.0%)
Mar 2018
-
$2.69B(-4.0%)
$10.90B(+2.4%)
Dec 2017
$10.64B(+6.8%)
$2.80B(+3.3%)
$10.64B(+2.9%)
Sep 2017
-
$2.71B(-0.2%)
$10.34B(+1.7%)
Jun 2017
-
$2.71B(+11.8%)
$10.17B(+1.9%)
Mar 2017
-
$2.43B(-2.7%)
$9.98B(+0.1%)
Dec 2016
$9.97B(+4.7%)
$2.49B(-1.8%)
$9.97B(-0.1%)
Sep 2016
-
$2.54B(+0.6%)
$9.98B(+0.7%)
Jun 2016
-
$2.52B(+4.6%)
$9.91B(+2.3%)
Mar 2016
-
$2.41B(-3.7%)
$9.69B(+1.8%)
Dec 2015
$9.52B(+11.6%)
$2.51B(+1.6%)
$9.52B(+1.8%)
Sep 2015
-
$2.47B(+7.0%)
$9.36B(+2.8%)
Jun 2015
-
$2.31B(+2.8%)
$9.10B(+2.0%)
Mar 2015
-
$2.24B(-4.3%)
$8.92B(+4.6%)
Dec 2014
$8.53B(+40.5%)
$2.34B(+6.1%)
$8.53B(+8.1%)
Sep 2014
-
$2.21B(+3.7%)
$7.90B(+8.5%)
Jun 2014
-
$2.13B(+15.1%)
$7.28B(+9.6%)
Mar 2014
-
$1.85B(+8.4%)
$6.64B(+9.4%)
Dec 2013
$6.07B(+22.2%)
$1.71B(+7.2%)
$6.07B(+7.5%)
Sep 2013
-
$1.59B(+6.7%)
$5.65B(+6.5%)
Jun 2013
-
$1.49B(+16.5%)
$5.30B(+4.1%)
Mar 2013
-
$1.28B(-0.2%)
$5.09B(+2.5%)
Dec 2012
$4.97B(+8.5%)
$1.28B(+3.0%)
$4.97B(-11.4%)
Sep 2012
-
$1.25B(-2.8%)
$5.61B(+6.2%)
Jun 2012
-
$1.28B(+10.6%)
$5.29B(+3.4%)
Mar 2012
-
$1.16B(-39.8%)
$5.11B(+1.2%)
Dec 2011
$4.58B(+6.2%)
$1.93B(+109.4%)
$5.05B(+19.0%)
Sep 2011
-
$919.94M(-17.0%)
$4.25B(-3.6%)
Jun 2011
-
$1.11B(+0.7%)
$4.41B(+0.1%)
Mar 2011
-
$1.10B(-1.7%)
$4.40B(+2.0%)
Dec 2010
$4.32B(+8.0%)
$1.12B(+3.6%)
$4.32B(+2.2%)
Sep 2010
-
$1.08B(-2.3%)
$4.22B(+1.3%)
Jun 2010
-
$1.11B(+9.3%)
$4.17B(+2.5%)
Mar 2010
-
$1.01B(-1.5%)
$4.07B(+1.8%)
Dec 2009
$4.00B(+8.1%)
$1.03B(+0.0%)
$4.00B(+1.5%)
Sep 2009
-
$1.03B(+2.4%)
$3.94B(+1.1%)
Jun 2009
-
$1.00B(+6.9%)
$3.89B(+2.7%)
Mar 2009
-
$938.29M(-3.0%)
$3.79B(+2.6%)
Dec 2008
$3.70B(+30.3%)
$967.75M(-1.8%)
$3.70B(+4.6%)
Sep 2008
-
$985.47M(+9.4%)
$3.53B(+8.5%)
Jun 2008
-
$901.04M(+7.1%)
$3.26B(+7.0%)
Mar 2008
-
$841.25M(+4.4%)
$3.04B(+7.3%)
Dec 2007
$2.84B(+17.8%)
$805.73M(+13.9%)
$2.84B(+6.0%)
Sep 2007
-
$707.62M(+2.7%)
$2.68B(+2.7%)
Jun 2007
-
$689.11M(+8.7%)
$2.61B(+4.3%)
Mar 2007
-
$633.96M(-1.9%)
$2.50B(+3.7%)
Dec 2006
$2.41B
$646.24M(+1.5%)
$2.41B(+53.1%)
DateAnnualQuarterlyTTM
Sep 2006
-
$636.70M(+9.4%)
$1.57B(+9.0%)
Jun 2006
-
$582.05M(+7.1%)
$1.44B(+3.4%)
Mar 2006
-
$543.68M(-387.1%)
$1.40B(+4.1%)
Dec 2005
$1.34B(+28.7%)
-$189.38M(-137.4%)
$1.34B(-5.5%)
Sep 2005
-
$506.65M(-5.2%)
$1.42B(+2.0%)
Jun 2005
-
$534.54M(+9.5%)
$1.39B(+11.9%)
Mar 2005
-
$488.19M(-538.5%)
$1.24B(+19.3%)
Dec 2004
$1.04B(-1156.2%)
-$111.33M(-123.3%)
$1.04B(+53.1%)
Sep 2004
-
$478.82M(+23.7%)
$680.16M(+100.5%)
Jun 2004
-
$387.03M(+34.9%)
$339.24M(+371.3%)
Mar 2004
-
$286.98M(-160.7%)
$71.98M(-173.0%)
Dec 2003
-$98.61M(-124.5%)
-$472.66M(-442.8%)
-$98.60M(-303.5%)
Sep 2003
-
$137.89M(+15.1%)
$48.46M(-69.1%)
Jun 2003
-
$119.77M(+2.9%)
$156.85M(-41.9%)
Mar 2003
-
$116.39M(-135.7%)
$270.13M(-32.9%)
Dec 2002
$402.76M(-55.5%)
-$325.59M(-232.2%)
$402.76M(-58.6%)
Sep 2002
-
$246.28M(+5.7%)
$972.06M(+1.8%)
Jun 2002
-
$233.05M(-6.4%)
$954.52M(+0.8%)
Mar 2002
-
$249.03M(+2.2%)
$946.85M(+4.5%)
Dec 2001
$905.80M(+13.2%)
$243.71M(+6.5%)
$905.73M(+3.7%)
Sep 2001
-
$228.74M(+1.5%)
$873.82M(+3.3%)
Jun 2001
-
$225.38M(+8.4%)
$845.81M(+3.1%)
Mar 2001
-
$207.90M(-1.8%)
$820.14M(+2.5%)
Dec 2000
$800.47M(+17.1%)
$211.80M(+5.5%)
$800.47M(+5.2%)
Sep 2000
-
$200.73M(+0.5%)
$760.70M(+1.8%)
Jun 2000
-
$199.72M(+6.1%)
$746.97M(+4.0%)
Mar 2000
-
$188.22M(+9.4%)
$718.08M(+5.1%)
Dec 1999
$683.43M(+41.5%)
$172.03M(-8.0%)
$683.28M(+7.0%)
Sep 1999
-
$187.00M(+9.5%)
$638.73M(+9.3%)
Jun 1999
-
$170.83M(+11.3%)
$584.53M(+10.0%)
Mar 1999
-
$153.42M(+20.4%)
$531.30M(+10.0%)
Dec 1998
$483.08M(+25.8%)
$127.48M(-4.0%)
$483.18M(+2.0%)
Sep 1998
-
$132.80M(+12.9%)
$473.76M(+9.3%)
Jun 1998
-
$117.60M(+11.7%)
$433.56M(+7.9%)
Mar 1998
-
$105.30M(-10.8%)
$401.66M(+4.7%)
Dec 1997
$383.86M(+54.4%)
$118.06M(+27.5%)
$383.76M(+9.9%)
Sep 1997
-
$92.60M(+8.1%)
$349.17M(+0.7%)
Jun 1997
-
$85.70M(-1.9%)
$346.87M(+14.8%)
Mar 1997
-
$87.40M(+4.7%)
$302.26M(+21.6%)
Dec 1996
$248.56M(+76.1%)
$83.47M(-7.6%)
$248.66M(+50.5%)
Sep 1996
-
$90.30M(+119.7%)
$165.20M(+52.1%)
Jun 1996
-
$41.10M(+21.6%)
$108.60M(+8.5%)
Mar 1996
-
$33.80M(+0.3%)
$100.10M(-24.2%)
Dec 1995
$141.19M(-3.6%)
-
-
Sep 1995
-
$33.70M(+3.4%)
$132.00M(+1.5%)
Jun 1995
-
$32.60M(+2.5%)
$130.00M(+0.1%)
Mar 1995
-
$31.80M(-6.2%)
$129.90M(-6.3%)
Dec 1994
$146.40M(+11.8%)
$33.90M(+6.9%)
$138.60M(-0.0%)
Sep 1994
-
$31.70M(-2.5%)
$138.60M(-0.6%)
Jun 1994
-
$32.50M(-19.8%)
$139.50M(-0.2%)
Mar 1994
-
$40.50M(+19.5%)
$139.80M(+6.9%)
Dec 1993
$130.90M(+7.7%)
$33.90M(+4.0%)
$130.80M(-31.8%)
Sep 1993
-
$32.60M(-0.6%)
$191.90M(+7.0%)
Jun 1993
-
$32.80M(+4.1%)
$179.30M(+20.0%)
Mar 1993
-
$31.50M(-66.8%)
$149.40M(+23.2%)
Dec 1992
$121.50M(+571.3%)
$95.00M(+375.0%)
$121.30M(+305.7%)
Sep 1992
-
$20.00M(+589.7%)
$29.90M(+121.5%)
Jun 1992
-
$2.90M(-14.7%)
$13.50M(-15.1%)
Mar 1992
-
$3.40M(-5.6%)
$15.90M(-12.2%)
Dec 1991
$18.10M(+23.1%)
$3.60M(0.0%)
$18.10M(-7.2%)
Sep 1991
-
$3.60M(-32.1%)
$19.50M(+2.1%)
Jun 1991
-
$5.30M(-5.4%)
$19.10M(+16.5%)
Mar 1991
-
$5.60M(+12.0%)
$16.40M(+12.3%)
Dec 1990
$14.70M(+345.5%)
$5.00M(+56.3%)
$14.60M(+49.0%)
Sep 1990
-
$3.20M(+23.1%)
$9.80M(+44.1%)
Jun 1990
-
$2.60M(-31.6%)
$6.80M(+61.9%)
Mar 1990
-
$3.80M(+1800.0%)
$4.20M(+950.0%)
Dec 1989
$3.30M(-760.0%)
$200.00K(0.0%)
$400.00K(+100.0%)
Sep 1989
-
$200.00K
$200.00K
Dec 1988
-$500.00K(-96.0%)
-
-
Dec 1987
-$12.40M(-26.6%)
-
-
Dec 1986
-$16.90M(-259.4%)
-
-
Dec 1985
$10.60M(-234.2%)
-
-
Dec 1984
-$7.90M
-
-

FAQ

  • What is Biogen annual gross profit?
  • What is the all time high annual gross profit for Biogen?
  • What is Biogen annual gross profit year-on-year change?
  • What is Biogen quarterly gross profit?
  • What is the all time high quarterly gross profit for Biogen?
  • What is Biogen quarterly gross profit year-on-year change?
  • What is Biogen TTM gross profit?
  • What is the all time high TTM gross profit for Biogen?
  • What is Biogen TTM gross profit year-on-year change?

What is Biogen annual gross profit?

The current annual gross profit of BIIB is $7.37B

What is the all time high annual gross profit for Biogen?

Biogen all-time high annual gross profit is $12.42B

What is Biogen annual gross profit year-on-year change?

Over the past year, BIIB annual gross profit has changed by +$63.30M (+0.87%)

What is Biogen quarterly gross profit?

The current quarterly gross profit of BIIB is $1.87B

What is the all time high quarterly gross profit for Biogen?

Biogen all-time high quarterly gross profit is $3.27B

What is Biogen quarterly gross profit year-on-year change?

Over the past year, BIIB quarterly gross profit has changed by +$44.10M (+2.41%)

What is Biogen TTM gross profit?

The current TTM gross profit of BIIB is $7.37B

What is the all time high TTM gross profit for Biogen?

Biogen all-time high TTM gross profit is $12.74B

What is Biogen TTM gross profit year-on-year change?

Over the past year, BIIB TTM gross profit has changed by +$103.20M (+1.42%)
On this page